nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP3A7—Ifosfamide—germ cell cancer	0.118	0.182	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.118	0.182	CbGbCtD
Triazolam—CYP3A5—Ifosfamide—germ cell cancer	0.0883	0.136	CbGbCtD
Triazolam—CYP2C8—Ifosfamide—germ cell cancer	0.0849	0.131	CbGbCtD
Triazolam—CYP2C9—Ifosfamide—germ cell cancer	0.0592	0.0913	CbGbCtD
Triazolam—CYP3A5—Etoposide—germ cell cancer	0.0422	0.0651	CbGbCtD
Triazolam—CYP2C8—Etoposide—germ cell cancer	0.0406	0.0626	CbGbCtD
Triazolam—CYP3A4—Ifosfamide—germ cell cancer	0.0344	0.0531	CbGbCtD
Triazolam—CYP2C9—Cisplatin—germ cell cancer	0.0288	0.0444	CbGbCtD
Triazolam—CYP3A4—Vinblastine—germ cell cancer	0.0183	0.0282	CbGbCtD
Triazolam—CYP3A4—Etoposide—germ cell cancer	0.0165	0.0254	CbGbCtD
Triazolam—CYP2C9—cardial valve—germ cell cancer	0.0112	0.0608	CbGeAlD
Triazolam—Incontinence—Ifosfamide—germ cell cancer	0.00543	0.0325	CcSEcCtD
Triazolam—Dysaesthesia—Ifosfamide—germ cell cancer	0.00439	0.0262	CcSEcCtD
Triazolam—GABRG1—ganglion—germ cell cancer	0.00435	0.0237	CbGeAlD
Triazolam—TSPO—appendage—germ cell cancer	0.00385	0.0209	CbGeAlD
Triazolam—Slurred speech—Cisplatin—germ cell cancer	0.00366	0.0219	CcSEcCtD
Triazolam—GABRA2—ganglion—germ cell cancer	0.00291	0.0158	CbGeAlD
Triazolam—Delusion—Ifosfamide—germ cell cancer	0.00268	0.016	CcSEcCtD
Triazolam—GABRR3—eye—germ cell cancer	0.00264	0.0143	CbGeAlD
Triazolam—GABRR3—retina—germ cell cancer	0.00262	0.0142	CbGeAlD
Triazolam—Mania—Ifosfamide—germ cell cancer	0.00261	0.0156	CcSEcCtD
Triazolam—Aggression—Bleomycin—germ cell cancer	0.00253	0.0151	CcSEcCtD
Triazolam—CYP2C9—urine—germ cell cancer	0.00241	0.0131	CbGeAlD
Triazolam—GABRQ—telencephalon—germ cell cancer	0.00241	0.0131	CbGeAlD
Triazolam—GABRR2—eye—germ cell cancer	0.00229	0.0124	CbGeAlD
Triazolam—GABRR2—retina—germ cell cancer	0.00227	0.0123	CbGeAlD
Triazolam—GABRA3—neck—germ cell cancer	0.00222	0.0121	CbGeAlD
Triazolam—Eye irritation—Ifosfamide—germ cell cancer	0.00222	0.0133	CcSEcCtD
Triazolam—GABRR1—eye—germ cell cancer	0.0022	0.012	CbGeAlD
Triazolam—GABRR1—retina—germ cell cancer	0.00218	0.0119	CbGeAlD
Triazolam—TSPO—blood vessel—germ cell cancer	0.00214	0.0117	CbGeAlD
Triazolam—Deafness—Vinblastine—germ cell cancer	0.00213	0.0128	CcSEcCtD
Triazolam—Dysarthria—Ifosfamide—germ cell cancer	0.00201	0.012	CcSEcCtD
Triazolam—Hearing impaired—Ifosfamide—germ cell cancer	0.00199	0.0119	CcSEcCtD
Triazolam—GABRA6—brainstem—germ cell cancer	0.00188	0.0102	CbGeAlD
Triazolam—CYP3A4—urine—germ cell cancer	0.00184	0.00999	CbGeAlD
Triazolam—Depressed level of consciousness—Ifosfamide—germ cell cancer	0.00183	0.011	CcSEcCtD
Triazolam—Disorientation—Bleomycin—germ cell cancer	0.0018	0.0108	CcSEcCtD
Triazolam—GABRD—telencephalon—germ cell cancer	0.00174	0.00949	CbGeAlD
Triazolam—Dysarthria—Cisplatin—germ cell cancer	0.00173	0.0103	CcSEcCtD
Triazolam—Hearing impaired—Cisplatin—germ cell cancer	0.00172	0.0103	CcSEcCtD
Triazolam—GABRG3—pituitary gland—germ cell cancer	0.00172	0.00933	CbGeAlD
Triazolam—GABRG1—telencephalon—germ cell cancer	0.00168	0.00913	CbGeAlD
Triazolam—Hepatic failure—Dactinomycin—germ cell cancer	0.00167	0.01	CcSEcCtD
Triazolam—GABRA6—telencephalon—germ cell cancer	0.00167	0.00908	CbGeAlD
Triazolam—GABRB1—telencephalon—germ cell cancer	0.00163	0.00885	CbGeAlD
Triazolam—GABRA5—telencephalon—germ cell cancer	0.00162	0.00881	CbGeAlD
Triazolam—GABRG2—trigeminal ganglion—germ cell cancer	0.00157	0.00851	CbGeAlD
Triazolam—Disorientation—Ifosfamide—germ cell cancer	0.00154	0.0092	CcSEcCtD
Triazolam—Deafness—Ifosfamide—germ cell cancer	0.00154	0.0092	CcSEcCtD
Triazolam—Hepatic failure—Ifosfamide—germ cell cancer	0.00153	0.00916	CcSEcCtD
Triazolam—TSPO—neck—germ cell cancer	0.00153	0.00834	CbGeAlD
Triazolam—GABRQ—head—germ cell cancer	0.0015	0.00814	CbGeAlD
Triazolam—GABRR3—head—germ cell cancer	0.0015	0.00814	CbGeAlD
Triazolam—GABRA4—telencephalon—germ cell cancer	0.00147	0.00799	CbGeAlD
Triazolam—Amnesia—Ifosfamide—germ cell cancer	0.00147	0.00876	CcSEcCtD
Triazolam—GABRE—trigeminal ganglion—germ cell cancer	0.00142	0.00771	CbGeAlD
Triazolam—GABRB2—brainstem—germ cell cancer	0.00139	0.00753	CbGeAlD
Triazolam—GABRP—decidua—germ cell cancer	0.00138	0.00752	CbGeAlD
Triazolam—Osteoarthritis—Ifosfamide—germ cell cancer	0.00138	0.00823	CcSEcCtD
Triazolam—GABRD—medulla oblongata—germ cell cancer	0.00137	0.00745	CbGeAlD
Triazolam—Deafness—Cisplatin—germ cell cancer	0.00133	0.00794	CcSEcCtD
Triazolam—GABRB1—pituitary gland—germ cell cancer	0.00133	0.00721	CbGeAlD
Triazolam—TSPO—trigeminal ganglion—germ cell cancer	0.00132	0.0072	CbGeAlD
Triazolam—GABRG1—medulla oblongata—germ cell cancer	0.00132	0.00717	CbGeAlD
Triazolam—GABRG3—head—germ cell cancer	0.00131	0.00713	CbGeAlD
Triazolam—Urinary retention—Ifosfamide—germ cell cancer	0.00131	0.00783	CcSEcCtD
Triazolam—GABRR2—head—germ cell cancer	0.0013	0.00706	CbGeAlD
Triazolam—GABRB1—medulla oblongata—germ cell cancer	0.00128	0.00696	CbGeAlD
Triazolam—TSPO—embryo—germ cell cancer	0.00128	0.00695	CbGeAlD
Triazolam—GABRG3—testis—germ cell cancer	0.00127	0.00689	CbGeAlD
Triazolam—GABRA2—brainstem—germ cell cancer	0.00127	0.00688	CbGeAlD
Triazolam—Amnesia—Cisplatin—germ cell cancer	0.00126	0.00756	CcSEcCtD
Triazolam—GABRD—midbrain—germ cell cancer	0.00125	0.00681	CbGeAlD
Triazolam—GABRR1—head—germ cell cancer	0.00125	0.0068	CbGeAlD
Triazolam—GABRG2—telencephalon—germ cell cancer	0.00123	0.00668	CbGeAlD
Triazolam—GABRB2—telencephalon—germ cell cancer	0.00123	0.00668	CbGeAlD
Triazolam—GABRA1—brainstem—germ cell cancer	0.00122	0.00665	CbGeAlD
Triazolam—Stomatitis—Bleomycin—germ cell cancer	0.00121	0.00724	CcSEcCtD
Triazolam—GABRP—uterus—germ cell cancer	0.00121	0.00658	CbGeAlD
Triazolam—GABRR1—testis—germ cell cancer	0.00121	0.00657	CbGeAlD
Triazolam—GABRG1—midbrain—germ cell cancer	0.00121	0.00656	CbGeAlD
Triazolam—GABRB3—trigeminal ganglion—germ cell cancer	0.0012	0.00653	CbGeAlD
Triazolam—GABRA4—pituitary gland—germ cell cancer	0.0012	0.0065	CbGeAlD
Triazolam—GABRP—pituitary gland—germ cell cancer	0.00119	0.00646	CbGeAlD
Triazolam—GABRG1—spinal cord—germ cell cancer	0.00118	0.0064	CbGeAlD
Triazolam—TSPO—brainstem—germ cell cancer	0.00117	0.00637	CbGeAlD
Triazolam—GABRB1—midbrain—germ cell cancer	0.00117	0.00636	CbGeAlD
Triazolam—GABRR2—cerebellum—germ cell cancer	0.00116	0.0063	CbGeAlD
Triazolam—CYP3A7—endocrine gland—germ cell cancer	0.00115	0.00627	CbGeAlD
Triazolam—GABRB1—spinal cord—germ cell cancer	0.00114	0.0062	CbGeAlD
Triazolam—TSPO—eye—germ cell cancer	0.00114	0.0062	CbGeAlD
Triazolam—Irritability—Cisplatin—germ cell cancer	0.00113	0.00678	CcSEcCtD
Triazolam—TSPO—retina—germ cell cancer	0.00113	0.00614	CbGeAlD
Triazolam—Stomatitis—Dactinomycin—germ cell cancer	0.00113	0.00675	CcSEcCtD
Triazolam—GABRA2—telencephalon—germ cell cancer	0.00112	0.00611	CbGeAlD
Triazolam—Dysuria—Ifosfamide—germ cell cancer	0.00111	0.00665	CcSEcCtD
Triazolam—GABRD—head—germ cell cancer	0.00109	0.00591	CbGeAlD
Triazolam—GABRQ—brain—germ cell cancer	0.00109	0.0059	CbGeAlD
Triazolam—GABRA1—telencephalon—germ cell cancer	0.00109	0.0059	CbGeAlD
Triazolam—Cramp muscle—Cisplatin—germ cell cancer	0.00107	0.00639	CcSEcCtD
Triazolam—Ill-defined disorder—Vinblastine—germ cell cancer	0.00107	0.00637	CcSEcCtD
Triazolam—GABRE—decidua—germ cell cancer	0.00106	0.00574	CbGeAlD
Triazolam—GABRD—testis—germ cell cancer	0.00105	0.00571	CbGeAlD
Triazolam—GABRG1—head—germ cell cancer	0.00105	0.00569	CbGeAlD
Triazolam—GABRA6—head—germ cell cancer	0.00104	0.00565	CbGeAlD
Triazolam—TSPO—telencephalon—germ cell cancer	0.00104	0.00565	CbGeAlD
Triazolam—Malaise—Vinblastine—germ cell cancer	0.00104	0.0062	CcSEcCtD
Triazolam—GABRB3—eye—germ cell cancer	0.00104	0.00563	CbGeAlD
Triazolam—Stomatitis—Ifosfamide—germ cell cancer	0.00104	0.00619	CcSEcCtD
Triazolam—GABRB1—head—germ cell cancer	0.00101	0.00551	CbGeAlD
Triazolam—GABRA5—head—germ cell cancer	0.00101	0.00548	CbGeAlD
Triazolam—GABRG2—pituitary gland—germ cell cancer	0.001	0.00544	CbGeAlD
Triazolam—Sweating increased—Cisplatin—germ cell cancer	0.001	0.00598	CcSEcCtD
Triazolam—Hypertension—Vinblastine—germ cell cancer	0.000993	0.00593	CcSEcCtD
Triazolam—TSPO—skin of body—germ cell cancer	0.000992	0.00539	CbGeAlD
Triazolam—TSPO—decidua—germ cell cancer	0.000985	0.00536	CbGeAlD
Triazolam—Cramp muscle—Etoposide—germ cell cancer	0.00098	0.00586	CcSEcCtD
Triazolam—Glossitis—Methotrexate—germ cell cancer	0.000974	0.00582	CcSEcCtD
Triazolam—GABRA5—testis—germ cell cancer	0.000974	0.0053	CbGeAlD
Triazolam—Erythema—Bleomycin—germ cell cancer	0.000971	0.0058	CcSEcCtD
Triazolam—GABRD—cerebellum—germ cell cancer	0.000969	0.00527	CbGeAlD
Triazolam—Discomfort—Vinblastine—germ cell cancer	0.000967	0.00578	CcSEcCtD
Triazolam—GABRG2—medulla oblongata—germ cell cancer	0.000966	0.00525	CbGeAlD
Triazolam—GABRB2—medulla oblongata—germ cell cancer	0.000966	0.00525	CbGeAlD
Triazolam—GABRA3—endocrine gland—germ cell cancer	0.000951	0.00517	CbGeAlD
Triazolam—GABRG3—brain—germ cell cancer	0.000951	0.00517	CbGeAlD
Triazolam—Dysarthria—Methotrexate—germ cell cancer	0.000949	0.00567	CcSEcCtD
Triazolam—Hallucination—Ifosfamide—germ cell cancer	0.000949	0.00567	CcSEcCtD
Triazolam—GABRB3—telencephalon—germ cell cancer	0.000944	0.00513	CbGeAlD
Triazolam—GABRA3—head—germ cell cancer	0.000939	0.0051	CbGeAlD
Triazolam—GABRG1—cerebellum—germ cell cancer	0.000933	0.00507	CbGeAlD
Triazolam—GABRA6—cerebellum—germ cell cancer	0.000928	0.00504	CbGeAlD
Triazolam—Visual impairment—Ifosfamide—germ cell cancer	0.000919	0.00549	CcSEcCtD
Triazolam—Sweating increased—Etoposide—germ cell cancer	0.000916	0.00548	CcSEcCtD
Triazolam—GABRA4—head—germ cell cancer	0.000915	0.00497	CbGeAlD
Triazolam—GABRR2—lymph node—germ cell cancer	0.000909	0.00494	CbGeAlD
Triazolam—GABRP—head—germ cell cancer	0.000908	0.00494	CbGeAlD
Triazolam—GABRA3—testis—germ cell cancer	0.000907	0.00493	CbGeAlD
Triazolam—GABRE—pituitary gland—germ cell cancer	0.000907	0.00493	CbGeAlD
Triazolam—GABRR1—brain—germ cell cancer	0.000906	0.00493	CbGeAlD
Triazolam—Erythema—Dactinomycin—germ cell cancer	0.000906	0.00541	CcSEcCtD
Triazolam—GABRB1—cerebellum—germ cell cancer	0.000905	0.00492	CbGeAlD
Triazolam—Ill-defined disorder—Bleomycin—germ cell cancer	0.000901	0.00538	CcSEcCtD
Triazolam—Anorexia—Vinblastine—germ cell cancer	0.000894	0.00534	CcSEcCtD
Triazolam—Stomatitis—Cisplatin—germ cell cancer	0.000892	0.00533	CcSEcCtD
Triazolam—Tinnitus—Ifosfamide—germ cell cancer	0.000889	0.00531	CcSEcCtD
Triazolam—GABRG2—midbrain—germ cell cancer	0.000883	0.0048	CbGeAlD
Triazolam—GABRB2—midbrain—germ cell cancer	0.000883	0.0048	CbGeAlD
Triazolam—Malaise—Bleomycin—germ cell cancer	0.000876	0.00523	CcSEcCtD
Triazolam—TSPO—gonad—germ cell cancer	0.000868	0.00472	CbGeAlD
Triazolam—Depressed level of consciousness—Methotrexate—germ cell cancer	0.000867	0.00518	CcSEcCtD
Triazolam—TSPO—uterus—germ cell cancer	0.000862	0.00469	CbGeAlD
Triazolam—GABRB2—spinal cord—germ cell cancer	0.000861	0.00468	CbGeAlD
Triazolam—GABRG2—spinal cord—germ cell cancer	0.000861	0.00468	CbGeAlD
Triazolam—GABRA1—medulla oblongata—germ cell cancer	0.000853	0.00464	CbGeAlD
Triazolam—TSPO—pituitary gland—germ cell cancer	0.000847	0.0046	CbGeAlD
Triazolam—Paraesthesia—Vinblastine—germ cell cancer	0.000843	0.00503	CcSEcCtD
Triazolam—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00084	0.00502	CcSEcCtD
Triazolam—Erythema—Ifosfamide—germ cell cancer	0.00083	0.00496	CcSEcCtD
Triazolam—Chest pain—Bleomycin—germ cell cancer	0.000827	0.00494	CcSEcCtD
Triazolam—Jaundice—Etoposide—germ cell cancer	0.000818	0.00489	CcSEcCtD
Triazolam—Stomatitis—Etoposide—germ cell cancer	0.000818	0.00489	CcSEcCtD
Triazolam—GABRA2—adrenal gland—germ cell cancer	0.000817	0.00444	CbGeAlD
Triazolam—TSPO—medulla oblongata—germ cell cancer	0.000817	0.00444	CbGeAlD
Triazolam—Discomfort—Bleomycin—germ cell cancer	0.000817	0.00488	CcSEcCtD
Triazolam—Malaise—Dactinomycin—germ cell cancer	0.000817	0.00488	CcSEcCtD
Triazolam—GABRA4—cerebellum—germ cell cancer	0.000816	0.00444	CbGeAlD
Triazolam—Decreased appetite—Vinblastine—germ cell cancer	0.000816	0.00487	CcSEcCtD
Triazolam—GABRE—adrenal gland—germ cell cancer	0.00081	0.0044	CbGeAlD
Triazolam—Constipation—Vinblastine—germ cell cancer	0.000802	0.00479	CcSEcCtD
Triazolam—Pain—Vinblastine—germ cell cancer	0.000802	0.00479	CcSEcCtD
Triazolam—Confusional state—Bleomycin—germ cell cancer	0.000799	0.00477	CcSEcCtD
Triazolam—Oedema—Bleomycin—germ cell cancer	0.000792	0.00474	CcSEcCtD
Triazolam—Visual impairment—Cisplatin—germ cell cancer	0.000792	0.00473	CcSEcCtD
Triazolam—GABRB3—gonad—germ cell cancer	0.000788	0.00428	CbGeAlD
Triazolam—GABRD—brain—germ cell cancer	0.000787	0.00428	CbGeAlD
Triazolam—GABRA1—midbrain—germ cell cancer	0.000779	0.00424	CbGeAlD
Triazolam—Feeling abnormal—Vinblastine—germ cell cancer	0.000773	0.00462	CcSEcCtD
Triazolam—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00077	0.0046	CcSEcCtD
Triazolam—GABRB3—pituitary gland—germ cell cancer	0.000769	0.00418	CbGeAlD
Triazolam—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000767	0.00458	CcSEcCtD
Triazolam—Tinnitus—Cisplatin—germ cell cancer	0.000766	0.00458	CcSEcCtD
Triazolam—GABRB2—head—germ cell cancer	0.000765	0.00416	CbGeAlD
Triazolam—GABRG2—head—germ cell cancer	0.000765	0.00416	CbGeAlD
Triazolam—Agitation—Ifosfamide—germ cell cancer	0.000763	0.00456	CcSEcCtD
Triazolam—Discomfort—Dactinomycin—germ cell cancer	0.000762	0.00455	CcSEcCtD
Triazolam—GABRA1—spinal cord—germ cell cancer	0.00076	0.00413	CbGeAlD
Triazolam—GABRG1—brain—germ cell cancer	0.000758	0.00412	CbGeAlD
Triazolam—TSPO—adrenal gland—germ cell cancer	0.000756	0.00411	CbGeAlD
Triazolam—Anorexia—Bleomycin—germ cell cancer	0.000755	0.00451	CcSEcCtD
Triazolam—GABRE—female gonad—germ cell cancer	0.000755	0.00411	CbGeAlD
Triazolam—GABRA6—brain—germ cell cancer	0.000753	0.0041	CbGeAlD
Triazolam—Malaise—Ifosfamide—germ cell cancer	0.000748	0.00447	CcSEcCtD
Triazolam—TSPO—midbrain—germ cell cancer	0.000747	0.00406	CbGeAlD
Triazolam—Abdominal pain—Vinblastine—germ cell cancer	0.000742	0.00443	CcSEcCtD
Triazolam—GABRB3—medulla oblongata—germ cell cancer	0.000742	0.00403	CbGeAlD
Triazolam—GABRB2—testis—germ cell cancer	0.000739	0.00402	CbGeAlD
Triazolam—Oedema—Dactinomycin—germ cell cancer	0.000739	0.00442	CcSEcCtD
Triazolam—GABRB1—brain—germ cell cancer	0.000735	0.004	CbGeAlD
Triazolam—Palpitations—Ifosfamide—germ cell cancer	0.000733	0.00438	CcSEcCtD
Triazolam—TSPO—bone marrow—germ cell cancer	0.000732	0.00398	CbGeAlD
Triazolam—GABRA5—brain—germ cell cancer	0.000731	0.00397	CbGeAlD
Triazolam—TSPO—spinal cord—germ cell cancer	0.000728	0.00396	CbGeAlD
Triazolam—Hepatic failure—Methotrexate—germ cell cancer	0.000725	0.00433	CcSEcCtD
Triazolam—Hypertension—Ifosfamide—germ cell cancer	0.000716	0.00428	CcSEcCtD
Triazolam—Erythema—Cisplatin—germ cell cancer	0.000715	0.00428	CcSEcCtD
Triazolam—Paraesthesia—Bleomycin—germ cell cancer	0.000712	0.00425	CcSEcCtD
Triazolam—Dyspnoea—Bleomycin—germ cell cancer	0.000707	0.00422	CcSEcCtD
Triazolam—Chest pain—Ifosfamide—germ cell cancer	0.000706	0.00422	CcSEcCtD
Triazolam—TSPO—female gonad—germ cell cancer	0.000705	0.00383	CbGeAlD
Triazolam—Flatulence—Cisplatin—germ cell cancer	0.000705	0.00421	CcSEcCtD
Triazolam—Anorexia—Dactinomycin—germ cell cancer	0.000705	0.00421	CcSEcCtD
Triazolam—GABRA2—head—germ cell cancer	0.000699	0.0038	CbGeAlD
Triazolam—Discomfort—Ifosfamide—germ cell cancer	0.000698	0.00417	CcSEcCtD
Triazolam—GABRE—head—germ cell cancer	0.000693	0.00377	CbGeAlD
Triazolam—Hypersensitivity—Vinblastine—germ cell cancer	0.000691	0.00413	CcSEcCtD
Triazolam—Decreased appetite—Bleomycin—germ cell cancer	0.000689	0.00412	CcSEcCtD
Triazolam—Visual disturbance—Methotrexate—germ cell cancer	0.000688	0.00411	CcSEcCtD
Triazolam—Muscle spasms—Cisplatin—germ cell cancer	0.000688	0.00411	CcSEcCtD
Triazolam—GABRG2—cerebellum—germ cell cancer	0.000683	0.00371	CbGeAlD
Triazolam—GABRB2—cerebellum—germ cell cancer	0.000683	0.00371	CbGeAlD
Triazolam—Confusional state—Ifosfamide—germ cell cancer	0.000683	0.00408	CcSEcCtD
Triazolam—GABRA3—brain—germ cell cancer	0.00068	0.0037	CbGeAlD
Triazolam—GABRB3—midbrain—germ cell cancer	0.000678	0.00369	CbGeAlD
Triazolam—Pain—Bleomycin—germ cell cancer	0.000678	0.00405	CcSEcCtD
Triazolam—Oedema—Ifosfamide—germ cell cancer	0.000677	0.00405	CcSEcCtD
Triazolam—GABRA1—head—germ cell cancer	0.000676	0.00367	CbGeAlD
Triazolam—Asthenia—Vinblastine—germ cell cancer	0.000673	0.00402	CcSEcCtD
Triazolam—Tremor—Cisplatin—germ cell cancer	0.00067	0.00401	CcSEcCtD
Triazolam—GABRE—testis—germ cell cancer	0.00067	0.00364	CbGeAlD
Triazolam—Ill-defined disorder—Cisplatin—germ cell cancer	0.000664	0.00397	CcSEcCtD
Triazolam—GABRA4—brain—germ cell cancer	0.000663	0.00361	CbGeAlD
Triazolam—GABRB3—spinal cord—germ cell cancer	0.000661	0.0036	CbGeAlD
Triazolam—TSPO—endocrine gland—germ cell cancer	0.000656	0.00357	CbGeAlD
Triazolam—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000655	0.00391	CcSEcCtD
Triazolam—Feeling abnormal—Bleomycin—germ cell cancer	0.000653	0.0039	CcSEcCtD
Triazolam—Osteoarthritis—Methotrexate—germ cell cancer	0.000652	0.0039	CcSEcCtD
Triazolam—TSPO—head—germ cell cancer	0.000647	0.00352	CbGeAlD
Triazolam—Anorexia—Ifosfamide—germ cell cancer	0.000646	0.00386	CcSEcCtD
Triazolam—Malaise—Cisplatin—germ cell cancer	0.000645	0.00386	CcSEcCtD
Triazolam—Decreased appetite—Dactinomycin—germ cell cancer	0.000642	0.00384	CcSEcCtD
Triazolam—Diarrhoea—Vinblastine—germ cell cancer	0.000642	0.00384	CcSEcCtD
Triazolam—Dysgeusia—Etoposide—germ cell cancer	0.000642	0.00384	CcSEcCtD
Triazolam—Fatigue—Dactinomycin—germ cell cancer	0.000637	0.00381	CcSEcCtD
Triazolam—Pain—Dactinomycin—germ cell cancer	0.000632	0.00378	CcSEcCtD
Triazolam—Muscle spasms—Etoposide—germ cell cancer	0.00063	0.00377	CcSEcCtD
Triazolam—TSPO—testis—germ cell cancer	0.000625	0.0034	CbGeAlD
Triazolam—GABRA2—cerebellum—germ cell cancer	0.000624	0.00339	CbGeAlD
Triazolam—Irritability—Methotrexate—germ cell cancer	0.000622	0.00372	CcSEcCtD
Triazolam—Dizziness—Vinblastine—germ cell cancer	0.00062	0.00371	CcSEcCtD
Triazolam—Mood swings—Methotrexate—germ cell cancer	0.000618	0.00369	CcSEcCtD
Triazolam—Ataxia—Methotrexate—germ cell cancer	0.000613	0.00366	CcSEcCtD
Triazolam—Feeling abnormal—Dactinomycin—germ cell cancer	0.000609	0.00364	CcSEcCtD
Triazolam—Paraesthesia—Ifosfamide—germ cell cancer	0.000608	0.00363	CcSEcCtD
Triazolam—Ill-defined disorder—Etoposide—germ cell cancer	0.000608	0.00363	CcSEcCtD
Triazolam—Anxiety—Cisplatin—germ cell cancer	0.000607	0.00363	CcSEcCtD
Triazolam—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000604	0.00361	CcSEcCtD
Triazolam—Dyspnoea—Ifosfamide—germ cell cancer	0.000604	0.00361	CcSEcCtD
Triazolam—GABRA1—cerebellum—germ cell cancer	0.000603	0.00328	CbGeAlD
Triazolam—Somnolence—Ifosfamide—germ cell cancer	0.000602	0.0036	CcSEcCtD
Triazolam—Discomfort—Cisplatin—germ cell cancer	0.000602	0.0036	CcSEcCtD
Triazolam—Vomiting—Vinblastine—germ cell cancer	0.000597	0.00356	CcSEcCtD
Triazolam—GABRB3—endocrine gland—germ cell cancer	0.000595	0.00324	CbGeAlD
Triazolam—Malaise—Etoposide—germ cell cancer	0.000591	0.00353	CcSEcCtD
Triazolam—Decreased appetite—Ifosfamide—germ cell cancer	0.000589	0.00352	CcSEcCtD
Triazolam—GABRB3—head—germ cell cancer	0.000588	0.0032	CbGeAlD
Triazolam—Headache—Vinblastine—germ cell cancer	0.000588	0.00351	CcSEcCtD
Triazolam—Abdominal pain—Dactinomycin—germ cell cancer	0.000584	0.00349	CcSEcCtD
Triazolam—Fatigue—Ifosfamide—germ cell cancer	0.000584	0.00349	CcSEcCtD
Triazolam—Oedema—Cisplatin—germ cell cancer	0.000584	0.00349	CcSEcCtD
Triazolam—Hypersensitivity—Bleomycin—germ cell cancer	0.000584	0.00349	CcSEcCtD
Triazolam—CYP2C8—pituitary gland—germ cell cancer	0.000581	0.00316	CbGeAlD
Triazolam—Constipation—Ifosfamide—germ cell cancer	0.000579	0.00346	CcSEcCtD
Triazolam—Pain—Ifosfamide—germ cell cancer	0.000579	0.00346	CcSEcCtD
Triazolam—TSPO—cerebellum—germ cell cancer	0.000578	0.00314	CbGeAlD
Triazolam—Loss of consciousness—Etoposide—germ cell cancer	0.000576	0.00344	CcSEcCtD
Triazolam—Tachycardia—Cisplatin—germ cell cancer	0.00057	0.00341	CcSEcCtD
Triazolam—Asthenia—Bleomycin—germ cell cancer	0.000569	0.0034	CcSEcCtD
Triazolam—GABRB3—testis—germ cell cancer	0.000568	0.00309	CbGeAlD
Triazolam—Hypertension—Etoposide—germ cell cancer	0.000566	0.00338	CcSEcCtD
Triazolam—Hyperhidrosis—Cisplatin—germ cell cancer	0.000564	0.00337	CcSEcCtD
Triazolam—Pruritus—Bleomycin—germ cell cancer	0.000561	0.00335	CcSEcCtD
Triazolam—Feeling abnormal—Ifosfamide—germ cell cancer	0.000558	0.00334	CcSEcCtD
Triazolam—Chest pain—Etoposide—germ cell cancer	0.000558	0.00333	CcSEcCtD
Triazolam—Nausea—Vinblastine—germ cell cancer	0.000557	0.00333	CcSEcCtD
Triazolam—Anorexia—Cisplatin—germ cell cancer	0.000557	0.00333	CcSEcCtD
Triazolam—GABRG2—brain—germ cell cancer	0.000555	0.00302	CbGeAlD
Triazolam—GABRB2—brain—germ cell cancer	0.000555	0.00302	CbGeAlD
Triazolam—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000554	0.00331	CcSEcCtD
Triazolam—Discomfort—Etoposide—germ cell cancer	0.000551	0.00329	CcSEcCtD
Triazolam—Hypersensitivity—Dactinomycin—germ cell cancer	0.000545	0.00325	CcSEcCtD
Triazolam—Confusional state—Etoposide—germ cell cancer	0.000539	0.00322	CcSEcCtD
Triazolam—Abdominal pain—Ifosfamide—germ cell cancer	0.000535	0.0032	CcSEcCtD
Triazolam—Asthenia—Dactinomycin—germ cell cancer	0.00053	0.00317	CcSEcCtD
Triazolam—Dysuria—Methotrexate—germ cell cancer	0.000527	0.00315	CcSEcCtD
Triazolam—GABRB3—cerebellum—germ cell cancer	0.000524	0.00285	CbGeAlD
Triazolam—Paraesthesia—Cisplatin—germ cell cancer	0.000524	0.00313	CcSEcCtD
Triazolam—Tachycardia—Etoposide—germ cell cancer	0.000522	0.00312	CcSEcCtD
Triazolam—Dyspnoea—Cisplatin—germ cell cancer	0.000521	0.00311	CcSEcCtD
Triazolam—Hyperhidrosis—Etoposide—germ cell cancer	0.000517	0.00309	CcSEcCtD
Triazolam—Anorexia—Etoposide—germ cell cancer	0.00051	0.00305	CcSEcCtD
Triazolam—Decreased appetite—Cisplatin—germ cell cancer	0.000508	0.00303	CcSEcCtD
Triazolam—GABRA2—brain—germ cell cancer	0.000507	0.00276	CbGeAlD
Triazolam—Diarrhoea—Dactinomycin—germ cell cancer	0.000506	0.00302	CcSEcCtD
Triazolam—Vomiting—Bleomycin—germ cell cancer	0.000504	0.00301	CcSEcCtD
Triazolam—GABRE—brain—germ cell cancer	0.000503	0.00273	CbGeAlD
Triazolam—Drowsiness—Methotrexate—germ cell cancer	0.000502	0.003	CcSEcCtD
Triazolam—Pain—Cisplatin—germ cell cancer	0.000499	0.00298	CcSEcCtD
Triazolam—Dermatitis—Bleomycin—germ cell cancer	0.000499	0.00298	CcSEcCtD
Triazolam—Hypersensitivity—Ifosfamide—germ cell cancer	0.000499	0.00298	CcSEcCtD
Triazolam—GABRA1—brain—germ cell cancer	0.00049	0.00266	CbGeAlD
Triazolam—GABRA2—lymph node—germ cell cancer	0.00049	0.00266	CbGeAlD
Triazolam—Stomatitis—Methotrexate—germ cell cancer	0.00049	0.00293	CcSEcCtD
Triazolam—Asthenia—Ifosfamide—germ cell cancer	0.000486	0.0029	CcSEcCtD
Triazolam—GABRE—lymph node—germ cell cancer	0.000486	0.00264	CbGeAlD
Triazolam—Feeling abnormal—Cisplatin—germ cell cancer	0.000481	0.00288	CcSEcCtD
Triazolam—Paraesthesia—Etoposide—germ cell cancer	0.00048	0.00287	CcSEcCtD
Triazolam—Pruritus—Ifosfamide—germ cell cancer	0.000479	0.00286	CcSEcCtD
Triazolam—Dyspnoea—Etoposide—germ cell cancer	0.000477	0.00285	CcSEcCtD
Triazolam—Somnolence—Etoposide—germ cell cancer	0.000476	0.00284	CcSEcCtD
Triazolam—Nausea—Bleomycin—germ cell cancer	0.000471	0.00281	CcSEcCtD
Triazolam—Vomiting—Dactinomycin—germ cell cancer	0.00047	0.00281	CcSEcCtD
Triazolam—TSPO—brain—germ cell cancer	0.000469	0.00255	CbGeAlD
Triazolam—Decreased appetite—Etoposide—germ cell cancer	0.000465	0.00278	CcSEcCtD
Triazolam—Diarrhoea—Ifosfamide—germ cell cancer	0.000463	0.00277	CcSEcCtD
Triazolam—Fatigue—Etoposide—germ cell cancer	0.000461	0.00276	CcSEcCtD
Triazolam—Pain—Etoposide—germ cell cancer	0.000457	0.00273	CcSEcCtD
Triazolam—Constipation—Etoposide—germ cell cancer	0.000457	0.00273	CcSEcCtD
Triazolam—TSPO—lymph node—germ cell cancer	0.000453	0.00246	CbGeAlD
Triazolam—CYP2C8—endocrine gland—germ cell cancer	0.00045	0.00245	CbGeAlD
Triazolam—Dizziness—Ifosfamide—germ cell cancer	0.000448	0.00268	CcSEcCtD
Triazolam—Feeling abnormal—Etoposide—germ cell cancer	0.000441	0.00263	CcSEcCtD
Triazolam—Nausea—Dactinomycin—germ cell cancer	0.000439	0.00262	CcSEcCtD
Triazolam—Gastrointestinal pain—Etoposide—germ cell cancer	0.000437	0.00261	CcSEcCtD
Triazolam—CYP3A5—female gonad—germ cell cancer	0.000437	0.00237	CbGeAlD
Triazolam—Visual impairment—Methotrexate—germ cell cancer	0.000435	0.0026	CcSEcCtD
Triazolam—Vomiting—Ifosfamide—germ cell cancer	0.000431	0.00257	CcSEcCtD
Triazolam—Hypersensitivity—Cisplatin—germ cell cancer	0.00043	0.00257	CcSEcCtD
Triazolam—CYP2C8—testis—germ cell cancer	0.000429	0.00233	CbGeAlD
Triazolam—Dermatitis—Ifosfamide—germ cell cancer	0.000427	0.00255	CcSEcCtD
Triazolam—GABRB3—brain—germ cell cancer	0.000426	0.00232	CbGeAlD
Triazolam—Abdominal pain—Etoposide—germ cell cancer	0.000423	0.00253	CcSEcCtD
Triazolam—Tinnitus—Methotrexate—germ cell cancer	0.00042	0.00251	CcSEcCtD
Triazolam—Asthenia—Cisplatin—germ cell cancer	0.000419	0.0025	CcSEcCtD
Triazolam—CYP3A5—endocrine gland—germ cell cancer	0.000406	0.00221	CbGeAlD
Triazolam—Nausea—Ifosfamide—germ cell cancer	0.000402	0.0024	CcSEcCtD
Triazolam—CYP2C9—endocrine gland—germ cell cancer	0.0004	0.00217	CbGeAlD
Triazolam—Diarrhoea—Cisplatin—germ cell cancer	0.000399	0.00239	CcSEcCtD
Triazolam—Hypersensitivity—Etoposide—germ cell cancer	0.000394	0.00236	CcSEcCtD
Triazolam—Erythema—Methotrexate—germ cell cancer	0.000393	0.00235	CcSEcCtD
Triazolam—Dysgeusia—Methotrexate—germ cell cancer	0.000384	0.0023	CcSEcCtD
Triazolam—Asthenia—Etoposide—germ cell cancer	0.000384	0.00229	CcSEcCtD
Triazolam—Pruritus—Etoposide—germ cell cancer	0.000378	0.00226	CcSEcCtD
Triazolam—Vomiting—Cisplatin—germ cell cancer	0.000371	0.00222	CcSEcCtD
Triazolam—Dermatitis—Cisplatin—germ cell cancer	0.000368	0.0022	CcSEcCtD
Triazolam—Diarrhoea—Etoposide—germ cell cancer	0.000366	0.00219	CcSEcCtD
Triazolam—Ill-defined disorder—Methotrexate—germ cell cancer	0.000364	0.00218	CcSEcCtD
Triazolam—Malaise—Methotrexate—germ cell cancer	0.000354	0.00212	CcSEcCtD
Triazolam—Dizziness—Etoposide—germ cell cancer	0.000354	0.00211	CcSEcCtD
Triazolam—Nausea—Cisplatin—germ cell cancer	0.000347	0.00207	CcSEcCtD
Triazolam—Vomiting—Etoposide—germ cell cancer	0.00034	0.00203	CcSEcCtD
Triazolam—Dermatitis—Etoposide—germ cell cancer	0.000337	0.00201	CcSEcCtD
Triazolam—Headache—Etoposide—germ cell cancer	0.000335	0.002	CcSEcCtD
Triazolam—Chest pain—Methotrexate—germ cell cancer	0.000334	0.002	CcSEcCtD
Triazolam—Discomfort—Methotrexate—germ cell cancer	0.00033	0.00197	CcSEcCtD
Triazolam—Confusional state—Methotrexate—germ cell cancer	0.000323	0.00193	CcSEcCtD
Triazolam—CYP2C8—brain—germ cell cancer	0.000322	0.00175	CbGeAlD
Triazolam—Nausea—Etoposide—germ cell cancer	0.000318	0.0019	CcSEcCtD
Triazolam—Hyperhidrosis—Methotrexate—germ cell cancer	0.00031	0.00185	CcSEcCtD
Triazolam—Anorexia—Methotrexate—germ cell cancer	0.000305	0.00183	CcSEcCtD
Triazolam—CYP3A4—endocrine gland—germ cell cancer	0.000305	0.00166	CbGeAlD
Triazolam—Insomnia—Methotrexate—germ cell cancer	0.00029	0.00173	CcSEcCtD
Triazolam—Paraesthesia—Methotrexate—germ cell cancer	0.000288	0.00172	CcSEcCtD
Triazolam—Dyspnoea—Methotrexate—germ cell cancer	0.000286	0.00171	CcSEcCtD
Triazolam—Somnolence—Methotrexate—germ cell cancer	0.000285	0.0017	CcSEcCtD
Triazolam—Decreased appetite—Methotrexate—germ cell cancer	0.000279	0.00166	CcSEcCtD
Triazolam—Fatigue—Methotrexate—germ cell cancer	0.000276	0.00165	CcSEcCtD
Triazolam—Pain—Methotrexate—germ cell cancer	0.000274	0.00164	CcSEcCtD
Triazolam—Feeling abnormal—Methotrexate—germ cell cancer	0.000264	0.00158	CcSEcCtD
Triazolam—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000262	0.00157	CcSEcCtD
Triazolam—Abdominal pain—Methotrexate—germ cell cancer	0.000253	0.00151	CcSEcCtD
Triazolam—Hypersensitivity—Methotrexate—germ cell cancer	0.000236	0.00141	CcSEcCtD
Triazolam—Asthenia—Methotrexate—germ cell cancer	0.00023	0.00137	CcSEcCtD
Triazolam—Pruritus—Methotrexate—germ cell cancer	0.000227	0.00135	CcSEcCtD
Triazolam—Diarrhoea—Methotrexate—germ cell cancer	0.000219	0.00131	CcSEcCtD
Triazolam—Dizziness—Methotrexate—germ cell cancer	0.000212	0.00127	CcSEcCtD
Triazolam—Vomiting—Methotrexate—germ cell cancer	0.000204	0.00122	CcSEcCtD
Triazolam—Dermatitis—Methotrexate—germ cell cancer	0.000202	0.00121	CcSEcCtD
Triazolam—Headache—Methotrexate—germ cell cancer	0.000201	0.0012	CcSEcCtD
Triazolam—Nausea—Methotrexate—germ cell cancer	0.00019	0.00114	CcSEcCtD
